Company: LIMN
Filing Date: 2025-02-07
Form Type: 424B3
Source: 0001104659-25-010605
Chunk: 785

Company: Liminatus Pharma, Inc.
Filing Date: 2025-02-07
Form: 424B3
Chunk 785
---
“

#### Demanding Holder
” shall have the meaning given in subsection 2.1.4 .

“

#### Effectiveness Deadline
” shall have the meaning given in subsection 2.1.1 .

“

#### Equity PIPE Subscribers
” shall have the meaning given in the Preamble.

<div align='center'>H-2</div>

TABLE OF CONTENTS

“

#### Equity Subscription Agreement
” shall have the meaning given in the Recitals.

“

#### Exchange Act
” shall mean the Securities Exchange Act of 1934, as it may be amended from time to time.

“

#### Filing Deadline
” shall have the meaning set forth in subsection 2.1.1 .

“

#### Form S-1 Shelf
” shall have the meaning given in subsection 2.1.1 .

“

#### Form S-3 Shelf
” shall have the meaning given in subsection 2.3 .

“

#### Holder
” and “

#### Holders
” shall have the meaning given in the Preamble.

“

#### Insider Letter
” shall mean that certain letter agreement, dated as of the date hereof, by and among the Company, the Sponsor and each of the Company’s officers, directors, director nominees and advisors.

“

#### Liminatus
” shall have the meaning given in the Recitals.

“

#### Liminatus Members
” shall have the meaning given in the Preamble.

“

#### Liminatus Merger Sub
” shall have the meaning given in the Recitals.

“

#### Lock-up Period
” shall mean, with respect to 1/3 of the Lock-up Shares the period ending on the date that is 6 months following the Closing (as defined in the Transaction Agreement), with respect to an additional 1/3 of the Lock-up Shares, the period ending on the date that is 12 months following the Closing, and with respect to the remainder of the Lock-up Shares, the period ending on the date that is 24 months following the Closing; provided that the Lock-up Period shall immediately end on (x) the date on which the VWAP of the Common Stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 Trading Days within any 30-Trading Day period or (y) the date on which the Company completes a liquidation, merger, capital stock exchange, reorganization or other similar transaction that results in all of the Company’s stock